Home Reimbursed medicines Acid ursodeoxycholic
Acid ursodeoxycholic — maximum prices and reimbursement
The CANAMED catalogue contains 42 medicines with the active substance Acid ursodeoxycholic, from 5 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Acid ursodeoxycholic there are 42 authorised medicines in the CANAMED catalogue, with maximum retail prices between 48.38 and 266.02 RON, from 5 manufacturers. For 8 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Acid ursodeoxycholic
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| URSOLITH 250 mg | VITEMA S.A. - ROMANIA | 48.38 RON | 90% · A · and C1, C2 CNAS pays ~38.63 RON; you ~9.75 RON* |
P6L |
| URSOFALK 250 mg | DR. FALK PHARMA GMBH - GERMANIA | 66.18 RON | 90% · A · and C1, C2 CNAS pays ~38.63 RON; you ~27.55 RON* |
P6L |
| URSOGRIX 250 mg | AS GRINDEKS - LETONIA | 85.85 RON | 90% · A · and C1, C2 CNAS pays ~77.27 RON; you ~8.58 RON* |
PRF |
| URSOLITH 250 mg | VITEMA S.A. - ROMANIA | 85.85 RON | 90% · A · and C1, C2 CNAS pays ~77.27 RON; you ~8.58 RON* |
P6L |
| URSOLITH 250 mg | VITEMA S.A. - ROMANIA | 85.85 RON | 90% · A · and C1, C2 CNAS pays ~77.27 RON; you ~8.58 RON* |
P6L |
| URSOFALK 250 mg/5 ml | DR. FALK PHARMA GMBH - GERMANIA | 114.43 RON | 90% · A · and C1, C2 CNAS pays ~38.63 RON; you ~75.80 RON* |
P6L |
| URSOFALK 250 mg | DR. FALK PHARMA GMBH - GERMANIA | 118.09 RON | 90% · A · and C1, C2 CNAS pays ~77.27 RON; you ~40.82 RON* |
P6L |
| URSOFALK 500 mg | DR. FALK PHARMA GMBH - GERMANIA | 266.02 RON | 90% · A · and C1, C2 CNAS pays ~154.53 RON; you ~111.49 RON* |
P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ABC FARMACEUTICI S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| URSOFALK 250 mg/5 ml | DR. FALK PHARMA GMBH - GERMANIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| URSOFALK 500 mg | DR. FALK PHARMA GMBH - GERMANIA | from 118.09 RON (shelf) | not reimbursed | P6L |
| URSOGRIX 250 mg | AS GRINDEKS - LETONIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOGRIX 250 mg | AS GRINDEKS - LETONIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 250 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
| URSOVYX 500 mg | ICE S.P.A. - ITALIA | from 118.09 RON (shelf) | not reimbursed | PRF |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- P6L — With a medical prescription valid for 6 months (P-6L)
- PRF — With a medical prescription kept by the pharmacy (P-RF)
Live pharmacy prices
Products with Acid ursodeoxycholic in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
- Ursofalk 250mg, 100 capsule, Dr. Falk
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 250 mg
- ACID URSODEOXICOLIC PHARMACEUTICAL INNOVATION 500 mg
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Apixaban
- Atorvastatin
- Atomoxetin
- Aripiprazol
- Abirateron
- Amoxicillin + acid clavulanic
- Allopurinol
- Amlodipin
- Adalimumab
- Aciclovir
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Acid ursodeoxycholic
-
Is Acid ursodeoxycholic reimbursed?
Yes. For 8 of the catalogue entries with Acid ursodeoxycholic we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Acid ursodeoxycholic?
The maximum retail prices (the CANAMED legal cap) for medicines with Acid ursodeoxycholic are between 48.38 and 266.02 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Acid ursodeoxycholic is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Acid ursodeoxycholic are in the CANAMED catalogue?
The CANAMED catalogue holds 42 authorised medicines with the active substance Acid ursodeoxycholic — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go